GlassScriptPhysician profile
Sue A Douglas
NPI 1497750731
$4,580.27
in general payments reported to CMS, 2019-2025
25 companies · $1,007 in 2025
The $1,007 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $457 · 2021: $492 · 2022: $670 · 2023: $872 · 2024: $910 · 2025: $1,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,625 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,624.70 |
| Education | $164.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $714.31 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| Pfizer INC. | $517.28 | 2020-2025 | |
| Galderma Laboratories, L.P. | $395.61 | 2020-2025 | Nemluvio, Aklief |
| Abbvie INC. | $377.18 | 2021-2025 | Rinvoq, Skyrizi |
| Regeneron Healthcare Solutions, INC. | $299.54 | 2019-2025 | Dupixent |
| Genzyme Corporation | $287.57 | 2020-2025 | |
| Mayne Pharma Commercial LLC | $265.29 | 2022-2024 | |
| Incyte Corporation | $250.34 | 2021-2025 | Opzelura |
| Journey Medical Corporation | $199.47 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $198.99 | 2020-2023 | |
| Leo Pharma INC. | $168.56 | 2022-2024 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $144.82 | 2021-2025 | Cabtreo |
| Arcutis Biotherapeutics, INC. | $112.79 | 2023-2025 | Zoryve |
| Prugen, INC. Pharmaceuticals | $109.53 | 2019-2020 | |
| Organon LLC | $103.40 | 2025 | Vtama |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $85.25 | 2024-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $69.93 | 2023-2024 | Winlevi |
| Almirall LLC | $59.46 | 2024-2025 | Seysara |
| Dermira, INC. | $57.77 | 2020-2021 | |
| Krystal Biotech INC | $55.70 | 2023-2024 | Vyjuvek |
| Genentech USA, INC. | $34.60 | 2022-2023 | Xolair |
| Dermavant Sciences, INC. | $28.67 | 2022-2023 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $14.83 | 2024 | Sotyktu |
| Strata Skin Sciences, INC. | $14.82 | 2023 | Xtrac |
| Janssen Biotech, INC. | $14.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sue Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.